His Children Wanted Prostate Cancer Treated. He Chose Monitoring.

The number on the portal was 6.4. He copied it into a notebook, closed the laptop, then opened it again when his daughter called.

She had already seen the result. His son joined the call from another state. Both adult children spoke with the clipped urgency they used when a flight was canceled or a pipe had burst, except this problem had been sitting inside their father for nearly two years.

The notebook lay beside his hand. Each page held a month, a PSA result, and whatever the specialist had said would happen next. The first recorded result was 5.8.

Now the number was higher, though it had moved up and down between those tests, and his children treated the latest rise as proof that waiting had failed.

He did not.

At 66, after 31 years teaching middle school history, he was accustomed to letting a room settle before he spoke. Retirement had not removed that habit. He listened while his daughter described surgery and his son repeated that cancer should be taken out before it had a chance to spread.

Then he turned to the latest page. Beside 6.4, he had written that the specialist had reviewed the result and wanted to keep the planned follow-up appointment.

That sentence did not calm anyone. It did give him somewhere to put his finger.

The decision his family could not see

The cancer had been found after a routine visit with his primary care doctor in March 2023. A blood test led to another test, then an appointment with a specialist. A biopsy found a small amount of cancer that the specialist described as low risk. The pathology report included terms the family had never needed before, including Grade Group 1.

His children heard prostate cancer and expected a treatment date. Instead, the specialist discussed active surveillance, a plan that would monitor the cancer through repeat PSA tests, office visits, imaging, and another biopsy when indicated. Treatment remained available if later findings showed meaningful change.

The retired teacher heard structure. His children heard postponement.

He spent six weeks reading the material from the doctor’s office and talking with his partner. He also met with another specialist for a second opinion. Both clinicians described active surveillance as a reasonable option in his circumstances, while also explaining that monitoring could lead to treatment later and that no plan removed uncertainty.

What stayed with him was the possible cost of treating a cancer that might remain slow-growing. The consultations included frank discussion of urinary leakage and sexual changes after surgery, along with bowel or urinary problems that can follow radiation. None of those outcomes was guaranteed. Neither was avoiding them.

He chose surveillance.

His daughter asked him to reconsider. His son sent links to articles about newer treatment methods, usually late at night, and followed up if his father did not respond. Their concern came from attention, but attention could feel like pressure when every family call returned to the same decision.

The notebook became his defense against the idea that he was doing nothing. On the inside page, he wrote active surveillance in large letters. Beneath it, he recorded that the next blood test was due in six months.

Six months at a time

The first follow-up PSA was 6.1. His daughter focused on the increase from 5.8, while he focused on the specialist’s explanation that a PSA result could move for more than one reason and had to be considered alongside other information.

He did not try to teach the medicine back to her. He knew enough to know where his knowledge ended. Still, he wanted the family to understand that one result had not erased the rest of the plan, which included reviewing the trend and deciding whether the next step should change.

The next result was 5.7.

Relief arrived, but it was awkward. His son treated the lower number as good news, even though he had argued that the earlier rise proved monitoring was unsafe. Nobody mentioned the contradiction. They ordered dinner and talked about a leaking window in his daughter’s house.

For a while, the cancer stayed in its lane.

He attended appointments without his children. This bothered them. They said another person should be there to take notes, and he understood the practical point, but he also wanted one place where he remained a patient rather than a father whose decisions were being reviewed.

His partner sometimes came. Afterward, he transferred the consequential details into the notebook: the result, the next interval, and whether the specialist saw a reason to alter the plan. Other pieces stayed out. He did not record the parking cost or every phrase used in the exam room.

The notebook was not a transcript. It was the part he needed to carry home.

A repeat MRI showed no finding that led the specialist to recommend immediate treatment. A later biopsy still showed low-risk disease. His children accepted those results for a few months, though acceptance was never the same as comfort.

The family began using different language. His daughter stopped saying that he was waiting and started saying that he was being monitored. His son still preferred treatment, but he asked about the next appointment instead of sending another article.

Then the PSA reached 6.4.

The number changed the room again

The portal released the result before the specialist had discussed it with him. His children had access because he had shared the login during the first weeks after diagnosis, when everyone was frightened and he thought openness would reduce the pressure.

Instead, the number reached them without context.

By the time the family spoke, his daughter had opened several treatment pages. His son wanted to know whether they should find another opinion. Their father had not yet heard the specialist’s interpretation, but the family was already debating a decision that had not been placed in front of him.

He looked down at the notebook and noticed that the blank space beside 6.4 was bothering him more than the number. Every earlier line had a next step. This one did not, at least not yet.

He told his children he would talk after the follow-up appointment. That boundary did not come naturally. For most of their lives, he had answered their calls and helped solve the problem in front of them, even when the problem was a dead car battery or a rent payment they were embarrassed to mention.

Cancer changed the direction of that care. They wanted to protect him, and he wanted room to make a decision without having to manage their fear at the same time.

At the appointment, the specialist reviewed the PSA pattern, the previous imaging, and the biopsy findings. The monitoring plan continued, with another blood test scheduled after a shorter interval. The possibility of treatment was still present. It was not being activated by that result alone.

He wrote the new interval in the notebook. Then he called his children.

The conversation was not peaceful. His son said he remained uneasy, and his daughter asked for a copy of the visit summary. Their father agreed to share it, though he declined another round of treatment research. The family did not reach a common opinion.

They reached a temporary arrangement.

Future results would go to him first. He would speak with the specialist before the family discussed a number, unless the doctor’s office contacted him with a reason not to wait. His children could ask about the plan. They would not ask him to defend the entire decision every six months.

What seriousness looked like at home

Active surveillance occupied less of his daily life than his family imagined. Most mornings, there was no decision to make. He walked, read the newspaper, and made lunch with his partner. He volunteered at the library twice a month, where nobody knew his PSA result and nobody needed to.

The notebook stayed in a kitchen drawer.

Before appointments, he took it out and read the earlier pages. The figures still carried fear, especially when they rose, but they also showed that fear had not been the only event. There had been specialist reviews, a repeat biopsy, and long stretches when the plan remained unchanged.

His children began to notice those stretches. His daughter sometimes called without mentioning cancer. His son stopped checking the portal, though the shared access remained. None of them became relaxed about the diagnosis.

Eight months after the 6.4 result, another PSA test was approaching. The familiar tension returned. His daughter asked when he expected the result, then caught herself and said she would wait until he had spoken with the specialist.

He thanked her. He did not call that progress.

On the next page of the notebook, he wrote the month and left the rest of the line empty.

Questions people ask

Does active surveillance mean prostate cancer is being ignored?

In this story, surveillance included PSA tests, specialist visits, imaging, and repeat biopsy, with treatment still available if later findings changed the picture. The retired teacher experienced it as a medical plan, although his children initially heard the absence of immediate treatment as inaction.

Why did one

PSA result create so much family conflict?

The result appeared in the portal before the specialist had explained it, leaving the family to interpret one number on its own. Earlier fluctuations had already trained his children to treat every increase as danger, while he relied on the broader record in his notebook and the planned follow-up.

How did the family handle future test results?

They agreed that he would review each result with the specialist before the family discussed it, unless the doctor’s office raised an immediate concern. His children could ask about the next step without reopening the whole treatment decision. During those calls, the notebook stayed open beside the laptop.